341 related articles for article (PubMed ID: 19187507)
41. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
Sobel JD; Kapernick PS; Zervos M; Reed BD; Hooton T; Soper D; Nyirjesy P; Heine MW; Willems J; Panzer H; Wittes H
Am J Obstet Gynecol; 2001 Aug; 185(2):363-9. PubMed ID: 11518893
[TBL] [Abstract][Full Text] [Related]
42. A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women.
Bisanz JE; Seney S; McMillan A; Vongsa R; Koenig D; Wong L; Dvoracek B; Gloor GB; Sumarah M; Ford B; Herman D; Burton JP; Reid G
PLoS One; 2014; 9(8):e104511. PubMed ID: 25127240
[TBL] [Abstract][Full Text] [Related]
43. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients.
Anukam KC; Osazuwa EO; Osadolor HB; Bruce AW; Reid G
J Clin Gastroenterol; 2008 Mar; 42(3):239-43. PubMed ID: 18223503
[TBL] [Abstract][Full Text] [Related]
44. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
Fan SR; Liu XP
Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
[TBL] [Abstract][Full Text] [Related]
45. Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial.
Wolff BJ; Price TK; Joyce CJ; Wolfe AJ; Mueller ER
Int Urol Nephrol; 2019 Dec; 51(12):2149-2159. PubMed ID: 31535332
[TBL] [Abstract][Full Text] [Related]
46. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME; Betsi GI; Athanasiou S
J Antimicrob Chemother; 2006 Aug; 58(2):266-72. PubMed ID: 16790461
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
48. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.
Brand SR; Degenhardt TP; Person K; Sobel JD; Nyirjesy P; Schotzinger RJ; Tavakkol A
Am J Obstet Gynecol; 2018 Jun; 218(6):624.e1-624.e9. PubMed ID: 29534874
[TBL] [Abstract][Full Text] [Related]
49. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
50. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
Dausset C; Bornes S; Miquel S; Kondjoyan N; Angenieux M; Nakusi L; Veisseire P; Alaterre E; Bermúdez-Humarán LG; Langella P; Engel E; Forestier C; Nivoliez A
Sci Rep; 2020 Oct; 10(1):17074. PubMed ID: 33051479
[TBL] [Abstract][Full Text] [Related]
51. Intravaginal administration of gelatine capsules containing freeze-dried autochthonous lactobacilli: a double-blind, randomised clinical trial of safety.
De Gregorio PR; Maldonado NC; Pingitore EV; Terraf MCL; Tomás MSJ; de Ruiz CS; Santos V; Wiese B; Bru E; Paiz MC; Reina MF; Schujman DE; Nader-Macías MEF
Benef Microbes; 2020 Feb; 11(1):5-17. PubMed ID: 32066254
[TBL] [Abstract][Full Text] [Related]
52. Comparative study of fluconazole and clotrimazole for the treatment of vulvovaginal candidiasis.
O-Prasertsawat P; Bourlert A
Sex Transm Dis; 1995; 22(4):228-30. PubMed ID: 7482105
[TBL] [Abstract][Full Text] [Related]
53. Improved treatment of vulvovaginal candidiasis with Clotrimazole plus probiotic Lacidophilin Vaginal Capsules: A prospective, real-world study.
Zeng X; An R; Li H; Zhang Y
Medicine (Baltimore); 2023 Jan; 102(1):e32664. PubMed ID: 36607885
[TBL] [Abstract][Full Text] [Related]
54. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.
Murina F; Graziottin A; Vicariotto F; De Seta F
J Clin Gastroenterol; 2014; 48 Suppl 1():S102-5. PubMed ID: 25291115
[TBL] [Abstract][Full Text] [Related]
55. [Combined single-day treatment in acute vulvovaginal candidosis].
Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
[TBL] [Abstract][Full Text] [Related]
56. Probiotic Lactobacilli for urogenital health in women.
Reid G
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S234-6. PubMed ID: 18685506
[TBL] [Abstract][Full Text] [Related]
57. Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis.
Boahen A; Chew SY; Neela VK; Than LTL
Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1681-1699. PubMed ID: 36881331
[TBL] [Abstract][Full Text] [Related]
58. New evidence on oral L. plantarum P17630 product in women with history of recurrent vulvovaginal candidiasis (RVVC): a randomized double-blind placebo-controlled study.
Vladareanu R; Mihu D; Mitran M; Mehedintu C; Boiangiu A; Manolache M; Vladareanu S
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):262-267. PubMed ID: 29364495
[TBL] [Abstract][Full Text] [Related]
59. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
Zhu Y; Shan Y; Fan S; Li J; Liu X
Mycopathologia; 2015 Feb; 179(1-2):111-8. PubMed ID: 25322705
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.
Mikamo H; Matsumizu M; Nakazuru Y; Okayama A; Nagashima M
J Infect Chemother; 2015 Jul; 21(7):520-6. PubMed ID: 25887336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
